Building this hour’s briefing
Fetching wire and national feeds…
Business6 outlets · 3 countries
Eli Lilly stock hit a record high Thursday thanks to a stronger-than-expected earnings report fueled by sales of weight loss drugs Monjuaro and Zepbound.
This briefing item
First published 3 hours ago (Oct 29, 2026, 4:01 PM UTC) · latest update Oct 29, 2026, 4:59 PM UTC
Independent
6
Public broadcasters
0
State-backed
0
Stance mix in this cluster
United States · 2
United Kingdom · 1Cross-referenced facts
Prism keeps a sentence only when at least two write-ups share the same core details. Adjectives that signal a take are stripped. This is not a verdict — it is the overlapping record.
Headlines in this cluster diverge enough that no sentence repeated cleanly. Shared names and figures are listed below; treat single-source claims as unverified here.
Claims that appeared in only one write-up, each labeled by outlet.
Earnings live updates: Eli Lilly stock pops as strong GLP-1 drug demand lifts results, ServiceNow stock plunges.
Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion.
Updated: Lilly beats revenue forecasts, lifting full-year outlook for third straight quarter.
Eli Lilly Raises 2026 Sales Outlook on Mounjaro, Zepbound Strength.
Eli Lilly stock hit a record high Thursday thanks to a stronger-than-expected earnings report fueled by sales of weight loss drugs Monjuaro and Zepbound.
Sources are ordered left → neutral → right so the spread is visible. Stance is a coarse editorial label for comparison, not a moral score. Timestamps are the time each item entered the feed.
Yahoo Finance
Global · Independent
news.google.com/rss/articles/CBMi_wFBVV95cUxQMDRyaWIzUkxSMFBjeE95dEhUSFlzMWh…
CNBC
United States · Independent
news.google.com/rss/articles/CBMidkFVX3lxTE9NdFQ3UUxsNVQtQmtLandjang0Nk5QZ2x…
Endpoints News
Global · Independent
news.google.com/rss/articles/CBMiekFVX3lxTE1LUUEyalQ2a2dkSUpvZC1IdTdOUjJyMXp…
Financial Times
United Kingdom · Independent
news.google.com/rss/articles/CBMihAFBVV95cUxPcHdIUEEwdGZjaHlvTnh2VGZoYW0ySkp…
TradingView
Global · Independent
news.google.com/rss/articles/CBMiwwFBVV95cUxQalV6VTI4SXlRMVJPbXdSU2NMd1pRVG9…
New York Post
United States · Independent
nypost.com/2026/10/29/business/demand-for-weight-loss-drugs-fuels-eli-l…
Eli Lilly stock hit a record high Thursday thanks to a stronger-than-expected earnings report fueled by sales of weight loss drugs Monjuaro and Zepbound.